Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gotlib

Showing results (71-80 of 247) with videos related to

Pageof 25
Sort By:
G3 (Bethesda, Md.)|August 13, 2017
Intricate and Cell Type-Specific Populations of Endogenous Circular DNA (eccDNA) in <i>Caenorhabditis elegans</i> and <i>Homo sapiens</i>Massa J Shoura, Idan Gabdank, Loren Hansen, et al.
Leukemia Research|December 3, 2014
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemiaMichaela Liedtke, Tamara Dunn, Shira Dinner, et al.
Blood Cancer Discovery|July 27, 2023
Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery ApproachesPramod C Nair, Jacob Piehler, Denis Tvorogov, et al.
Expert Review of Hematology|August 30, 2014
The serum tryptase test: an emerging robust biomarker in clinical hematologyPeter Valent, Wolfgang R Sperr, Karl Sotlar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 4, 2025
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic MastocytosisAndreas Reiter, Julien Rossignol, Michael W Deininger, et al.
Journal of Translational Medicine|September 12, 2015
Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosisCatriona Jamieson, Robert Hasserjian, Jason Gotlib, et al.
Journal of Hematopathology|July 15, 2026
A case of true acute eosinophilic leukemia arising from myelodysplastic syndromeQingyu Li, Matthew S Alkaitis, William Shomali, et al.
American Journal of Hematology|June 7, 2023
The international consensus classification of eosinophilic disorders and systemic mastocytosisSa A Wang, Attilio Orazi, Jason Gotlib, et al.
American Journal of Hematology|November 5, 2011
Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemiaBruno C Medeiros, Holbrook E Kohrt, Jason Gotlib, et al.
Cell Reports. Medicine|November 10, 2021
Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasmsZhu Shen, Wenfei Du, Cecelia Perkins, et al.
Pageof 25

Showing results (71-80 of 247) with videos related to

Sort By:
Pageof 25
G3 (Bethesda, Md.)|August 13, 2017
Intricate and Cell Type-Specific Populations of Endogenous Circular DNA (eccDNA) in <i>Caenorhabditis elegans</i> and <i>Homo sapiens</i>Massa J Shoura, Idan Gabdank, Loren Hansen, et al.
Leukemia Research|December 3, 2014
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemiaMichaela Liedtke, Tamara Dunn, Shira Dinner, et al.
Blood Cancer Discovery|July 27, 2023
Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery ApproachesPramod C Nair, Jacob Piehler, Denis Tvorogov, et al.
Expert Review of Hematology|August 30, 2014
The serum tryptase test: an emerging robust biomarker in clinical hematologyPeter Valent, Wolfgang R Sperr, Karl Sotlar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 4, 2025
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic MastocytosisAndreas Reiter, Julien Rossignol, Michael W Deininger, et al.
Journal of Translational Medicine|September 12, 2015
Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosisCatriona Jamieson, Robert Hasserjian, Jason Gotlib, et al.
Journal of Hematopathology|July 15, 2026
A case of true acute eosinophilic leukemia arising from myelodysplastic syndromeQingyu Li, Matthew S Alkaitis, William Shomali, et al.
American Journal of Hematology|June 7, 2023
The international consensus classification of eosinophilic disorders and systemic mastocytosisSa A Wang, Attilio Orazi, Jason Gotlib, et al.
American Journal of Hematology|November 5, 2011
Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemiaBruno C Medeiros, Holbrook E Kohrt, Jason Gotlib, et al.
Cell Reports. Medicine|November 10, 2021
Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasmsZhu Shen, Wenfei Du, Cecelia Perkins, et al.
Pageof 25